POMC PEPTIDE SYNTHESIS BY NORMAL AND AIDS LEUKOCYTES

正常和艾滋病白细胞合成 POMC 肽

基本信息

  • 批准号:
    3241617
  • 负责人:
  • 金额:
    $ 13.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1989
  • 资助国家:
    美国
  • 起止时间:
    1989-02-01 至 1992-01-31
  • 项目状态:
    已结题

项目摘要

The lethal defect in acquired immune deficiency syndrome (AIDS) is the profound defect in immune function caused by initial loss of helper T lymphocytes and eventually of all immune competent cells. Little has been published about hypothalamic-pituitary-adrenal (HPA) axis function in AIDS and AIDS-related complex (ARC), but cytomegalovirus adrenalitis, occasionally causing adrenal insufficiency, is surprisingly common. In addition, there is progressive loss of adrenocortical 18-hydroxylase activity in ARC and AIDS, perhaps reflecting loss of a factor separate from ACTH that stimulates aldosterone biosynthesis. With the immune system's first line of defense crippled, the HPA axis assumes an even greater importance in responding to the stress of infection. Furthermore, JE Blalock, EM Smith, WJ Meyer 111 and their coworkers have presented a body of data which indicate that immunocompetent cells produce proopiomelanocortin (POMC) peptides in response to the same agents that induce human leukocyte interferon (hlFN alpha), that POMC production is regulated by the same hormones that regulate anterior pituitary POMC peptide secretion and that these leukocyte-derived POMC peptides may act in an autocrine or paracrine fashion to modulate the immune response and can even directly stimulate adrenocortical steroid biosynthesis in hypophysectomized animals. These findings have potentially fundamentally important implications for regulation of the immune response and interaction of the immune and endocrine systems. However, the only three groups that have attempted to reproduce the findings of Blalock, Smith and Meyer have failed completely to do so. This, the lack of supporting data from other laboratories and questions of proper methodologic rigor raise reservations about this work, although there is little doubt that some immunocompetent cells can synthesize POMC peptides under appropriate conditions. We propose to examine rigorously the essential findings of these investigators, using independent, widely-accepted methods, and extend them by (1) detecting, quantifying and characterizing leukocyte POMC mRNA, (2) determining the concentrations of leukocyte POMC mRNA and peptides in the immune cells and POMC peptides in the medium after stimulation by various agents, (3) determining if there is a leukocyte-derived peptide that specifically stimulates aldosterone biosynthesis, (4) defining which subset(s) of immune cells produce POMC peptides in response to specific stimuli, (5) determining if leukocyte POMC peptide synthesis is impaired in ARC and AIDS and (6) assessing whether leukocyte POMC peptide production is impaired in response to febrile illnesses in AIDS patients. If the findings of Blalock et al are correct, they will be confirmed by the most rigorous examination and will be extended to define possible fundamental defects in immune regulation and immune-endocrine interactions in ARC and AIDS patients.
获得性免疫缺陷综合征(AIDS)的致命缺陷是

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID N ORTH其他文献

DAVID N ORTH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID N ORTH', 18)}}的其他基金

NORMAL AND ABNORMAL HYPOTHALAMIC PITUITARY ADRENAL FUNCTION IN CUSHINGS
库欣的正常和异常下丘脑垂体肾上腺功能
  • 批准号:
    6246691
  • 财政年份:
    1997
  • 资助金额:
    $ 13.8万
  • 项目类别:
CORE--HORMONE ASSAY
核心--激素测定
  • 批准号:
    6108199
  • 财政年份:
    1996
  • 资助金额:
    $ 13.8万
  • 项目类别:
CRH'S ROLE IN CAUSE AND RECOVERY FROM HYPERCORTISOLISM
CRH 在皮质醇增多症的病因和恢复中的作用
  • 批准号:
    2145276
  • 财政年份:
    1994
  • 资助金额:
    $ 13.8万
  • 项目类别:
CRH'S ROLE IN CAUSE AND RECOVERY FROM HYPERCORTISOLISM
CRH 在皮质醇增多症的病因和恢复中的作用
  • 批准号:
    2145277
  • 财政年份:
    1994
  • 资助金额:
    $ 13.8万
  • 项目类别:
CRH'S ROLE IN CAUSE AND RECOVERY FROM HYPERCORTISOLISM
CRH 在皮质醇增多症的病因和恢复中的作用
  • 批准号:
    2145275
  • 财政年份:
    1994
  • 资助金额:
    $ 13.8万
  • 项目类别:
POMC PEPTIDE SYNTHESIS BY NORMAL AND AIDS LEUKOCYTES
正常和艾滋病白细胞合成 POMC 肽
  • 批准号:
    3241618
  • 财政年份:
    1989
  • 资助金额:
    $ 13.8万
  • 项目类别:
POMC PEPTIDE SYNTHESIS BY NORMAL AND AIDS LEUKOCYTES
正常和艾滋病白细胞合成 POMC 肽
  • 批准号:
    3241616
  • 财政年份:
    1989
  • 资助金额:
    $ 13.8万
  • 项目类别:
CORTICOTROPIN-RELEASING HORMONE PHYSIOLOGY
促肾上腺皮质激素释放激素生理学
  • 批准号:
    3231739
  • 财政年份:
    1983
  • 资助金额:
    $ 13.8万
  • 项目类别:
CORTICOTROPIN-RELEASING HORMONE PHYSIOLOGY
促肾上腺皮质激素释放激素生理学
  • 批准号:
    3231745
  • 财政年份:
    1983
  • 资助金额:
    $ 13.8万
  • 项目类别:
CORTICOTROPIN-RELEASING FACTOR--HUMAN PHYSIOLOGY
促肾上腺皮质激素释放因子--人体生理学
  • 批准号:
    3152791
  • 财政年份:
    1983
  • 资助金额:
    $ 13.8万
  • 项目类别:

相似海外基金

A targeted combination intervention approach for acute HIV infections to curb the explosive epidemic among high-risk populations in Indonesia
针对急性艾滋病毒感染的针对性组合干预方法,遏制印度尼西亚高危人群的爆发性流行
  • 批准号:
    MR/V035304/1
  • 财政年份:
    2022
  • 资助金额:
    $ 13.8万
  • 项目类别:
    Research Grant
IMPAACT RELATED PROTOCOLS FOR THE RESEARCH ON TREATMENT, PREVENTION, DIAGNOSIS AND EPIDEMIOLOGY OF HIV INFECTIONS
HIV 感染的治疗、预防、诊断和流行病学研究的影响相关方案
  • 批准号:
    10369859
  • 财政年份:
    2021
  • 资助金额:
    $ 13.8万
  • 项目类别:
Determining the mechanisms of vascular CD8 T cell activation in CMV and HIV infections
确定 CMV 和 HIV 感染中血管 CD8 T 细胞激活的机制
  • 批准号:
    10461964
  • 财政年份:
    2021
  • 资助金额:
    $ 13.8万
  • 项目类别:
Determining the mechanisms of vascular CD8 T cell activation in CMV and HIV infections
确定 CMV 和 HIV 感染中血管 CD8 T 细胞激活的机制
  • 批准号:
    10326617
  • 财政年份:
    2021
  • 资助金额:
    $ 13.8万
  • 项目类别:
Combination HIV Prevention: Using anti-retroviral and anti-inflammatory medications to prevent new HIV infections
HIV 联合预防:使用抗逆转录病毒和抗炎药物预防新的 HIV 感染
  • 批准号:
    404211
  • 财政年份:
    2018
  • 资助金额:
    $ 13.8万
  • 项目类别:
    Operating Grants
BALTIMORE: PROJECTS TO REDUCE HIV INFECTIONS AND IMPROVE ENGAGEMENT IN HIV MEDICAL CARE AMONG MSM
巴尔的摩:减少艾滋病毒感染和提高男男性行为者参与艾滋病毒医疗护理的项目
  • 批准号:
    9078083
  • 财政年份:
    2015
  • 资助金额:
    $ 13.8万
  • 项目类别:
Health Department Demonstration Projects to Reduce HIV Infections and Improve Engagement in HIV Medical Care among Men Who Have Sex with Men (MSM) and Transgender Persons
卫生部示范项目旨在减少男男性行为者 (MSM) 和跨性别者的艾滋病毒感染并提高他们对艾滋病毒医疗护理的参与度
  • 批准号:
    9079323
  • 财政年份:
    2015
  • 资助金额:
    $ 13.8万
  • 项目类别:
REDUCING HIV INFECTIONS AND IMPROVING ENGAGEMENT IN HIV MEDICAL CARE AMONG MSM IN MEMPHIS TN
减少田纳西州孟菲斯市 MSM 的 HIV 感染并提高其对 HIV 医疗护理的参与度
  • 批准号:
    9079336
  • 财政年份:
    2015
  • 资助金额:
    $ 13.8万
  • 项目类别:
Double-Negative T cells in SIV and HIV Infections
SIV 和 HIV 感染中的双阴性 T 细胞
  • 批准号:
    8472130
  • 财政年份:
    2012
  • 资助金额:
    $ 13.8万
  • 项目类别:
REDUCING HIV INFECTIONS AMONG COMMERCIAL SEX WORKERS IN GERT SIBANDE DISTRICT TAV
减少格特西班德区 TAV 商业性工作者的艾滋病毒感染
  • 批准号:
    8532661
  • 财政年份:
    2011
  • 资助金额:
    $ 13.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了